Profile data is unavailable for this security.
About the company
iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu technology is an AI-based tool designed to predict a library of antibodies with fully human Complementarity-Determining Region (CDR) variants based on an input antibody. It is in the process of building its preclinical pipeline, which focuses primarily on immuno-oncology. Its pipeline includes IBIO-101, Endostatin E4, TROP-2 x CD3, MUC16, EGFRvIII, and CCR8. IBIO-101 is an anti-CD25 monoclonal antibody (mAb) that has demonstrated in preclinical models of disease the ability to bind and deplete immunosuppressive regulatory T (Treg) cells to inhibit the growth of solid tumors.
- Revenue in USD (TTM)50.00k
- Net income in USD-20.77m
- Incorporated2008
- Employees26.00
- LocationIbio Inc8800 HSC PkwyBRYAN 77807United StatesUSA
- Phone+1 (979) 446-0027
- Fax+1 (302) 636-5454
- Websitehttps://www.ibioinc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepion Pharmaceuticals Inc | 0.00 | -47.82m | 10.84m | 25.00 | -- | 0.6634 | -- | -- | -12.51 | -12.51 | 0.00 | 4.21 | 0.00 | -- | -- | 0.00 | -94.36 | -51.33 | -110.58 | -57.30 | -- | -- | -- | -- | -- | -4,805.57 | 0.00 | -- | -- | -- | -38.55 | -- | -- | -- |
Chemomab Therapeutics Ltd - ADR | 0.00 | -24.22m | 10.94m | 37.00 | -- | 0.6436 | -- | -- | -2.12 | -2.12 | 0.00 | 1.20 | 0.00 | -- | -- | -- | -74.28 | -- | -90.33 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 12.39 | -- | -- | -- |
Monopar Therapeutics Inc | 0.00 | -9.48m | 10.96m | 11.00 | -- | 1.58 | -- | -- | -0.713 | -0.713 | 0.00 | 0.4656 | 0.00 | -- | -- | 0.00 | -82.34 | -47.93 | -99.10 | -52.12 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -15.52 | -- | -- | -- |
Pioneer Green Farms Inc | 9.30k | -520.65k | 11.02m | 6.00 | -- | -- | -- | 1,185.43 | -0.0216 | -0.0216 | 0.0004 | -0.0272 | 0.0147 | 0.7101 | -- | 1,550.00 | -82.36 | -- | -- | -- | 41.40 | -- | -5,598.39 | -- | 0.0131 | -10.89 | 24.35 | -- | -100.00 | -- | -86.80 | -- | -- | -- |
Endexx Corp | 4.64m | 6.93m | 11.47m | -- | 1.71 | -- | 1.93 | 2.48 | 0.0133 | 0.0133 | 0.0091 | -0.0255 | 0.6773 | 4.37 | 13.54 | -- | 86.51 | -- | -- | -- | 28.73 | -- | 127.74 | -- | 0.0664 | -- | -- | -- | 228.66 | -- | 28.26 | -- | -- | -- |
Guardion Health Sciences Inc | 12.04m | -10.11m | 11.49m | 12.00 | -- | 1.49 | -- | 0.9544 | -8.20 | -8.20 | 9.55 | 6.04 | 0.5858 | 3.21 | 6.62 | 1,003,258.00 | -44.63 | -103.85 | -48.35 | -113.34 | 41.37 | 42.22 | -76.19 | -303.77 | 7.26 | -- | 0.00 | -- | 52.77 | 90.77 | 35.89 | -- | -31.63 | -- |
Ibio Inc | 50.00k | -20.77m | 11.71m | 26.00 | -- | 1.19 | -- | 234.14 | -21.91 | -27.30 | 0.0437 | 2.84 | 0.0012 | -- | 0.0129 | 1,923.08 | -48.41 | -28.09 | -113.84 | -32.63 | -- | -- | -41,546.00 | -1,467.30 | -- | -518.33 | 0.5942 | -- | -100.00 | -- | 0.9764 | -- | 42.90 | -- |
ELEVAI Labs Inc | 1.15m | -3.80m | 11.96m | 16.00 | -- | -- | -- | 10.37 | -0.2191 | -0.2191 | 0.0665 | -0.0095 | -- | -- | -- | -- | -- | -- | -- | -- | 66.47 | -- | -329.28 | -- | 0.4729 | -7.67 | -- | -- | 92,222.89 | -- | -129.41 | -- | -- | -- |
Inhibitor Therapeutics Inc | 0.00 | 10.46m | 12.04m | 3.00 | 2.76 | 1.87 | -- | -- | 0.0254 | 0.0254 | 0.00 | 0.0375 | 0.00 | -- | -- | 0.00 | 217.18 | 39.86 | 249.25 | 59.57 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | 2,489.99 | -- | -- | -- |
Eterna Therapeutics Inc | 68.00k | -21.68m | 12.12m | 8.00 | -- | 5.43 | -- | 178.22 | -4.08 | -4.08 | 0.0128 | 0.4128 | 0.0019 | -- | 0.0988 | 8,500.00 | -60.69 | -169.05 | -75.78 | -223.00 | -173.53 | -- | -31,864.71 | -682.61 | -- | -33.19 | 0.7813 | -- | -- | -68.89 | 11.84 | -- | -58.86 | -- |
Akari Therapeutics PLC (ADR) | 0.00 | -17.75m | 12.28m | 15.00 | -- | 3.87 | -- | -- | -5.68 | -5.68 | 0.00 | 0.4811 | 0.00 | -- | -- | 0.00 | -139.31 | -144.04 | -483.25 | -325.18 | -- | -- | -- | -- | -- | -15.77 | 0.00 | -- | -- | -- | -1.86 | -- | -- | -- |
Moleculin Biotech Inc | 0.00 | -26.27m | 12.34m | 15.00 | -- | 0.3134 | -- | -- | -13.52 | -13.52 | 0.00 | 17.68 | 0.00 | -- | -- | 0.00 | -50.09 | -44.48 | -55.51 | -48.83 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -82.62 | -- | 19.06 | -- |
BioNexus Gene Lab Corp | 10.34m | -3.09m | 12.37m | 9.00 | -- | 1.29 | -- | 1.20 | -0.1801 | -0.1801 | 0.6754 | 0.5445 | 1.07 | 8.11 | 5.70 | 1,148,592.00 | -32.12 | 4.60 | -37.99 | 6.29 | 13.56 | 14.80 | -29.92 | 3.52 | 4.36 | -204.89 | 0.00 | 0.00 | -18.21 | 151.93 | -147.36 | -- | -29.67 | -- |
Janone Inc | 39.61m | 155.00k | 12.50m | 199.00 | 25.34 | 0.8625 | 10.51 | 0.3157 | 0.0995 | 4.07 | 11.15 | 5.85 | 1.24 | -- | 12.55 | 199,050.30 | 0.4838 | -17.15 | 0.8217 | -40.73 | 19.23 | 23.82 | 0.3913 | -13.91 | -- | -- | 0.00 | -- | -1.03 | -0.9484 | 208.30 | 5.20 | 46.85 | -- |
Paranovus Entertainment Technology Ltd | 51.46m | -42.62m | 12.62m | 80.00 | -- | 1.18 | -- | 0.2452 | -7.16 | -7.49 | 9.89 | 1.46 | 1.18 | 59.61 | 4.15 | 643,209.90 | -91.12 | -23.19 | -119.36 | -27.21 | 4.92 | 23.09 | -77.15 | -24.25 | 3.97 | -2,465.22 | 0.00 | -- | 9.68 | 9.80 | -45.84 | -- | -21.93 | -- |
Intelligent Bio Solutions Inc | 2.46m | -13.40m | 12.66m | 17.00 | -- | 0.1669 | -- | 5.14 | -131.37 | -131.37 | 20.91 | 26.67 | 0.1831 | 2.41 | 9.09 | 144,726.50 | -99.96 | -80.65 | -157.15 | -224.84 | 20.90 | -- | -545.95 | -948.54 | 0.3864 | -- | 0.1602 | -- | 187.51 | 367.97 | -28.00 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Sabby Management LLCas of 31 Dec 2023 | 176.75k | 5.07% |
Citadel Securities LLCas of 31 Dec 2023 | 25.39k | 0.73% |
Warberg Asset Management LLCas of 31 Dec 2023 | 19.00k | 0.55% |
UBS Securities LLCas of 31 Dec 2023 | 18.00k | 0.52% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 6.89k | 0.20% |
Tower Research Capital LLCas of 31 Dec 2023 | 4.78k | 0.14% |
Pennsylvania State Employees' Retirement Systemas of 31 Dec 2021 | 411.00 | 0.01% |
Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2023 | 231.00 | 0.01% |
Morgan Stanley & Co. LLCas of 31 Dec 2023 | 108.00 | 0.00% |
RBC Dominion Securities, Inc.as of 31 Dec 2023 | 70.00 | 0.00% |